Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for Chronic Obstructive Pulmonary Disease (COPD)

 

Key Data:

Drug (Brand/Generic)
Ariflo (cilomilast)
Company/Licensee
GlaxoSmithKline Pharmaceuticals
Therapy Class
PDE-IV inhibitor
Product Description
Oral selective phosphodiesterase (PDE) IV inhibitor
Current Indication
Treatment of COPD
Market Sector
Respiratory
Development Status
Pre-registration



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development